Blood Cancer United, in partnership with Rally Foundation for Childhood Cancer Research, has launched Dare to Dream REALworld: AML, a patient-centered initiative to collect real-world data from pediatric acute myeloid leukemia (AML) patients and families. This data aims to accelerate research and improve clinical trials for new treatments by providing valuable evidence to researchers. The initiative also offers families access to Olivia, a health app to organize and understand their child's medical information. By building a comprehensive dataset, REALworld: AML hopes to enable more efficient trials and better treatment options for children with this rare cancer.
Blood Cancer United's new REALworld: AML initiative is the story subject, here is Pluang's health sector snapshot as of Nov 10, 2026 19:42 WIB: Out of 150 US health stocks, 83 rose and 55 fell. Notable movers include NUWE at USD 4.83 with 83% sell orders, INO at USD 1.48 with nearly balanced buy/sell orders, and AHCO at USD 7.21 with 100% buy orders. Typical hold times range from 21 to 41 days.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
